CD40LG and laryngotracheoesophageal cleft: Regarding EBV reactivation, EBV viremia or increased titers of anti-EBV antibodies (IgM/IgG against viral capsid antigen/VCA and IgG against EBV-encoded nuclear antigen/EBNA) may be early predictive biomarkers of LC.